Insider · CIK 0001716213
John P. Hamill
Files at APRE (Aprea Therapeutics, Inc.). First filing Oct 15, 2024, latest Oct 16, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
APRE: Aprea Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Aprea Therapeutics, Inc. | $123 50 shares | +0% | - | |
| 37Weak | Aprea Therapeutics, Inc. | $1,175 450 shares | +2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Common Stock | +3,365 | $0.00 | $0 | 22,733 | Mar 31, 2025 |
| Mar 27, 2025 | APRE Aprea Therapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +13,460 | $0.00 | $0 | 13,460 | Mar 31, 2025 |
| Oct 11, 2024 | APRE Aprea Therapeutics, Inc. | POpen-market purchase Common Stock | +50 | $2.46 | $123 | 19,368 | Oct 16, 2024 |
| Oct 10, 2024 | APRE Aprea Therapeutics, Inc. | POpen-market purchase Common Stock | +450 | $2.61 | $1,175 | 19,318 | Oct 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.